178449-60-0Relevant academic research and scientific papers
IMIDAZOPYRIDINE COMPOUNDS
-
Page/Page column 84, (2010/06/20)
The invention relates to compounds of formula (I): and their pharmaceutically acceptable salts and solvates, which are inhibitors of SSAO activity. The invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the treatment or prevention of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases and immune disorders.
Potential antitumor agents. 24. Synthesis and pharmacological behavior of imidazo[2,1-b]thiazole guanylhydrazones bearing at least one chlorine
Andreani, Aldo,Rambaldi, Mirella,Leoni, Alberto,Locatelli, Alessandra,Bossa, Rosaria,Fraccari, Alessandra,Galatulas, Iraklis,Salvatore, Gaetano
, p. 2852 - 2855 (2007/10/03)
In connection with a previous research dealing with the antitumor activity of imidazo[2,1-b]-thiazole guanylhydrazones, this paper reports the synthesis of new derivatives which were tested for antitumor and positive inotropic activity. In most cases the cytotoxic data from the in vitro experiments (HeLa) were in agreement with the antitumor data in vivo (Ehrlich). The active compounds bear a phenyl ring at the 6 position. On the other hand, the most active cardiotonic agents were devoid of the phenyl ring.
